Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study

被引:23
作者
Geraci, G. [1 ]
Palumbo, V. D. [1 ]
D'Orazio, B. [1 ]
Maffongelli, A. [1 ]
Fazzotta, S. [1 ]
Lo Monte, A., I [1 ]
机构
[1] Univ Teaching Hosp Paolo Giaccone Palermo, Sect Gen & Thorac Surg, Palermo, Italy
来源
CLINICA TERAPEUTICA | 2019年 / 170卷 / 05期
关键词
Diclofenac; ERCP; pancreatitis; complication; prevention; COMPLICATIONS;
D O I
10.7417/CT.2019.2156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Post-Endoscopic Retrograde Cholangio-Pancreatography pancreatitis (PEP) is a relevant (1-4%) complication of biliopancreatic operative endoscopy. Rectal nonsteroidal anti-inflammatory drugs (specifically, 100 mg of diclofenac) have shown promising prophylactic activity in PEP. The aim of our prospective study is to report whether prophylactic oral versus rectal suppository versus intramuscular diclofenac versus placebo are able to reduce the incidence and the severity of ERCP-induced pancreatitis. Materials and Methods. in this randomized, double-blinded, prospective study, 100 patients (49 male, 51 female), similar with regard to indication for ERCP, were enrolled between January 2016 and November 2017 to undergo ERCP in the Section of General and Thoracic Surgery of University Hospital of Palermo. They were randomized into five groups, respectively 20 patients with placebo by mouth; 20 patients with 50 mg diclofenac sodium enteric-coated capsules by mouth; 20 with 100 mg rectal suppository diclofenac, 20 with 75 mg/3 ml intramuscular diclofenac sodium, 20 with 75 mg/3 ml intramuscular diclofenac sodium and 20 with 75 mg/3 ml intravenous diclofenac. All drugs were administered 30 to 90 minutes before ERCP. All clinical data were collected one day before and 2, 12 and 24 hour after ERCP. Results. data were prospectively collected and to demonstrate the preventive effect of rectal diclofenac on PEP, a two-by-two table and chi-square test with Yates correction were used: the incidence of PEP was significantly lower (p < 0.001) in the rectal diclofenac group respect to other groups and, in the same way. the incidence of post-ERCP pain was significantly lower in the rectal diclofenac group than in the other groups (p = 0.001) and patients discharge was consequently earlier (p < 0.01). Conclusions. 100 mg dose rectal diclofenac administered 30-60 minutes before ERCP can effectively prevent PEP.
引用
收藏
页码:E332 / E336
页数:5
相关论文
共 50 条
  • [31] Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study
    Cardenas-Jaen, Karina
    Archibugi, Livia
    Poropat, Goran
    Korpela, Taija
    Maisonneuve, Patrick
    Aparicio, Jose R.
    Udd, Marianne
    Stimac, Davor
    Arcidiacono, Paolo G.
    De Pretis, Niccolo
    Valente, Roberto
    Di Giulio, Emilio
    Casellas, Juan A.
    Kylanpaa, Leena
    Hauser, Goran
    Mariani, Alberto
    Gabbrielli, Armando
    Lohr, Matthias
    Vanella, Giuseppe
    Rainio, Mia
    Brozzi, Lorenzo
    Arnelo, Urban
    Fagerstrom, Niklas
    Capurso, Gabriele
    de-Madaria, Enrique
    DIGESTIVE ENDOSCOPY, 2021, 33 (04) : 639 - 647
  • [32] Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study
    Fujishiro, Hirofumi
    Adachi, Kyoichi
    Imaoka, Tomonori
    Hashimoto, Tomoyuki
    Kohge, Naruaki
    Moriyama, Nobuyuki
    Suetsugu, Hiroshi
    Kawashima, Kousaku
    Komazawa, Yoshinori
    Ishimura, Norihisa
    Ishihara, Shunji
    Amano, Yuji
    Kinoshita, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 1065 - 1069
  • [33] Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs
    Park, Tae Young
    Oh, Hyoung-Chul
    Fogel, Evan L.
    Lehman, Glen A.
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (03) : 535 - 543
  • [34] Efficacy of low dose rectal diclofenac for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: Propensity score-matched analysis
    Tomoda, Takeshi
    Kato, Hironari
    Miyamoto, Kazuya
    Matsumi, Akihiro
    Ueta, Eijiro
    Fujii, Yuuki
    Saragai, Yousuke
    Yamazaki, Tatsuhiro
    Uchida, Daisuke
    Matsumoto, Kazuyuki
    Horiguchi, Shigeru
    Tsutsumi, Koichiro
    Okada, Hiroyuki
    DIGESTIVE ENDOSCOPY, 2021, 33 (04) : 656 - 662
  • [35] Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography
    Guglielmi, V.
    Tutino, M.
    Guerra, V.
    Giorgio, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (22) : 5268 - 5274
  • [36] Effect of rectal indomethacin on the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography for choledocholithiasis: a prospective randomized clinical trial
    Liu, Kai-Ji
    Hu, Yang
    Guo, Shi-Bin
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (04) : 201 - 208
  • [37] Risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis: Prospective single-institution study
    Tsuyuguchi, Toshio
    Okugawa, Tadahiro
    Yokosuka, Osamu
    DIGESTIVE ENDOSCOPY, 2007, 19 : S49 - S51
  • [38] Prognostic Factors for Severe-to-Fatal Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicenter Prospective Cohort Study
    Matsumoto, Kazuya
    Noma, Hisashi
    Fujita, Koichi
    Tomoda, Takeshi
    Onoyama, Takumi
    Hanada, Keiji
    Okazaki, Akihito
    Hirao, Ken
    Goto, Daisuke
    Moriyama, Ichiro
    Kushiyama, Yoshinori
    Takenaka, Mamoru
    Maruo, Toru
    Matsumoto, Hisakazu
    Asada, Masanori
    Nebiki, Hiroko
    Katayama, Toshihiro
    Kawamura, Takashi
    Kurita, Akira
    Ueki, Toshiharu
    Tsujimae, Masahiro
    Matsubara, Tokuhiro
    Yamada, Satoshi
    Tamura, Takashi
    Marui, Saiko
    Mitoro, Akira
    Isomoto, Hajime
    Yazumi, Shujiro
    Kawamoto, Hirofumi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [39] Effect of Adding Intravenous Somatostatin to Rectal Indomethacin on Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High-risk Patients A Double-blind Randomized Placebo-controlled Clinical Trial
    Norouzi, Alireza
    Poori, Eshrat Ghasem
    Kaabe, Sajjad
    Norouzi, Zahra
    Sohrabi, Ahmad
    Amlashi, Fazel I.
    Tavasoli, Samaneh
    Besharat, Sima
    Ezabadi, Zahra
    Amiriani, Taghi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (02) : 204 - 210
  • [40] Pancreatitis Potentially Associated Drugs as a Risk Factor for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis A Prospective Cohort Study
    Sigounas, Dimitrios E.
    Christodoulou, Dimitrios K.
    Tatsioni, Athina
    Katsanos, Konstantinos H.
    Baltayiannis, Gerasimos
    Kappas, Aggelos
    Ioannidis, John P. A.
    Tsianos, Epameinondas V.
    PANCREAS, 2013, 42 (04) : 601 - 606